Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: Follow-up of immunopathological and clinical effects

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Systemic sclerosis (SSc) is an autoimmune disease which involves the skin, as well as several internal organs. Most therapies available in this disease are symptomatic. Authors present a case of diffuse SSc with progressive disease not responding to currently available treatments. Therefore a 12-month protocol of repeated plasmapheresis and high-dose intravenous immunoglobulin treatment was administered with good clinical efficacy. Apart from monitoring the clinical symptoms throughout the treatment, authors also assessed a number of humoral and cellular immunolaboratory markers in order to obtain information on the immunomodulatory effects of this combined treatment in SSc.

Original languageEnglish
Pages (from-to)347-350
Number of pages4
JournalClinical rheumatology
Volume28
Issue number3
DOIs
Publication statusPublished - Jan 1 2009

    Fingerprint

Keywords

  • Intravenous immunoglobulin
  • Plasmapheresis
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology

Cite this